S. CROS

679 total citations
26 papers, 598 citations indexed

About

S. CROS is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, S. CROS has authored 26 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in S. CROS's work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). S. CROS is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). S. CROS collaborates with scholars based in France. S. CROS's co-authors include M. Morimoto, A Krikorian, J. P. Couzinier, Matthew C. Wright, Bernard Monsarrat, Claude Paoletti, Mark D. Wright, Françoise Guéritte-Voegelein, Daniel Guénard and Jean Pierre Souchard and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

S. CROS

26 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. CROS France	13	325	248	146	76	46	26	598
Kazuo Kuretani United Kingdom	14	383 1.2×	355 1.4×	261 1.8×	25 0.3×	52 1.1×	95	847
Mariagrazia Distefano Italy	14	265 0.8×	374 1.5×	96 0.7×	70 0.9×	78 1.7×	20	746
Joachim Blanz Germany	14	202 0.6×	536 2.2×	183 1.3×	51 0.7×	49 1.1×	31	967
Brian W. Fox United Kingdom	14	171 0.5×	334 1.3×	268 1.8×	23 0.3×	46 1.0×	35	721
Janet S. Macpherson United Kingdom	16	333 1.0×	385 1.6×	119 0.8×	77 1.0×	24 0.5×	30	861
Paulo Eduardo Pizão Netherlands	4	188 0.6×	224 0.9×	114 0.8×	19 0.3×	25 0.5×	5	448
Motoko Inomata Japan	13	113 0.3×	269 1.1×	124 0.8×	25 0.3×	69 1.5×	39	658
Ki Deok Shin South Korea	7	186 0.6×	404 1.6×	142 1.0×	87 1.1×	39 0.8×	7	711
Gérard Bastian France	15	315 1.0×	277 1.1×	120 0.8×	23 0.3×	21 0.5×	27	661
Karimullah A. Zirvi United States	11	123 0.4×	165 0.7×	63 0.4×	67 0.9×	16 0.3×	39	399

Countries citing papers authored by S. CROS

Since Specialization

Citations

This map shows the geographic impact of S. CROS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. CROS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. CROS more than expected).

Fields of papers citing papers by S. CROS

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. CROS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. CROS. The network helps show where S. CROS may publish in the future.

Co-authorship network of co-authors of S. CROS

This figure shows the co-authorship network connecting the top 25 collaborators of S. CROS. A scholar is included among the top collaborators of S. CROS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. CROS. S. CROS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grand, Xavier, et al.. (2012). Identification of positive and negative regulators of disease resistance to rice blast fungus using constitutive gene expression patterns. Plant Biotechnology Journal. 10(7). 840–850. 18 indexed citations

CROS, S., Bernard Bennetau, J. DUNOGUÈS, & Patrick J. Babin. (1994). Une synthèse originale et rapide de (méthyldiéthoxysilyl)benzènes fonctionnels. Journal of Organometallic Chemistry. 468(1-2). 69–74. 3 indexed citations

Helissey, Philippe, S. CROS, & Sylviane Giorgi‐Renault. (1994). Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.. PubMed. 9(1). 51–67. 12 indexed citations

Souchard, Jean Pierre, et al.. (1991). Hydrophobicity parameters for platinum complexes. Journal of Medicinal Chemistry. 34(2). 863–864. 42 indexed citations

Sombié, Pierre Alexandre Eric Djifaby, et al.. (1991). Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.. PubMed. 51(9). 2312–8. 44 indexed citations

Monsarrat, Bernard, et al.. (1990). Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile.. Drug Metabolism and Disposition. 18(6). 895–901. 102 indexed citations

Wimmer, Smita, et al.. (1989). The antitumor activity of some palladium(II) complexes with chelating ligands.. PubMed. 9(3). 791–3. 33 indexed citations

CROS, S., et al.. (1989). Experimental antitumor activity of Navelbine.. PubMed. 16(2 Suppl 4). 15–20. 117 indexed citations

Meunier, Gérard, Dominique de Montauzon, Jean Bernadou, et al.. (1988). The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?. Molecular Pharmacology. 33(1). 93–102. 28 indexed citations

10.

Auclair, Christian, Pierre Alexandre Eric Djifaby Sombié, Emmanuelle Voisin, et al.. (1987). Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.. PubMed. 47(23). 6254–61. 31 indexed citations

11.

CROS, S., et al.. (1986). Inhibition of tumor cell growth in vitro and in vivo by 2‐methyl 9‐hydroxyellipticinium entrapped within phospholipid vesicles. Biopharmaceutics & Drug Disposition. 7(4). 357–371. 2 indexed citations

12.

Giorgi‐Renault, Sylviane, et al.. (1985). Heterocyclic quinones. VI: Synthesis and antitumoral effects of 5,10-benzo [g] quinoxalinediones and aza-analogues. 20(2). 144–148. 8 indexed citations

13.

Monsarrat, Bernard, et al.. (1985). Cytochrome P-450-mediated O-demethylation of two ellipticine derivatives. Differential effect of the murine Ah locus phenotype.. Drug Metabolism and Disposition. 13(4). 497–502. 4 indexed citations

14.

Malvy, Claude, et al.. (1980). Nitro-9 et amino-9 ellipticines et dérivés: synthèse et propriétés pharmacologiques.. 35(11). 2 indexed citations

15.

Paoletti, Claude, P. Lecointe, P. Lesca, et al.. (1978). Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs. Biochimie. 60(9). 1003–1009. 19 indexed citations

16.

Gosse, Charlie, et al.. (1976). Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.. PubMed. 36(9 pt.1). 3067–76. 34 indexed citations

17.

CROS, S., et al.. (1975). Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice. Toxicology and Applied Pharmacology. 33(3). 484–497. 15 indexed citations

18.

Paoletti, Costanza, et al.. (1974). [Studies on the toxicity of 9-hydroxyellipticine].. PubMed. 278(10). 1437–40. 3 indexed citations

19.

CROS, S., et al.. (1972). [Tetramethylurea action on the embryonic development of the mouse].. PubMed. 30(9). 585–93. 6 indexed citations

20.

CROS, S., et al.. (1967). LIMITS OF TOXIC AND TERATOGENIC TOLERANCE OF DIMETHYL SULFOXIDE. Annals of the New York Academy of Sciences. 141(1). 110–125. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact